Effect of dofetilide on QT dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure

European Journal of Heart Failure

Volumn 4, Issue 2, 2002, Pages 201-206

  Brendorp, Bente ^a   Elming, Hanne ^a   Jun, Li ^a   Køber, Lars ^b   Torp Pedersen, Christian ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Antiarrhythmic agents; Arrhythmia; Heart failure; Prognosis; QT dispersion

Indexed keywords

ANTIARRHYTHMIC AGENT; DOFETILIDE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; PHENETHYLAMINES; POTASSIUM CHANNEL BLOCKERS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SULFONAMIDES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036126019     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00235-5     Document Type: Article

References (26)

1. Antiarrhythmic drug effects on QT interval dispersion in patients undergoing electropharmacologic testing for ventricular tachycardia and fibrillation
2. UK-68,798: A novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells
3. Influence of dofetilide on QT-interval duration and dispersion at various heart rates during exercise in humans
4. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris
5. Dofetilide in patients with congestive heart failure and left ventricular dysfunction
6. QTc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide
7. QT dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function
8. Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: Rationale, design, and patient characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality on Dofetilide
9. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study)
10. Statistical aspects of prognostic factor studies in oncology
11. The risk of determining risk with multivariable models
12. Reduction in QT dispersion by sotalol following myocardial infarction
13. Precordial QT interval dispersion as a marker of Torsade de pointes. Disparate effects of class la antiarrhythmic drugs and amiodarone
14. Effects of amiodarone, sematilide, and sotalol on QT dispersion
15. QT dispersion as an attribute of T-loop morphology
16. Reproducibility and automatic measurement of QT dispersion
17. Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion
18. Cardiac failure and sudden death in the Framingham study
19. QT dispersion and sudden unexpected death in chronic heart failure
20. QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy
21. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function
22. QT dispersion as a marker of risk in patients awaiting heart transplantation
23. QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology
24. QT interval dispersion in hospital patients admitted with cardiac insufficiency. Determinants and prognostic value
25. Prognosis in myocardial infarction survivors with left ventricular dysfunction is predicted by electrocardiographic RR interval but not QT dispersion
26. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The united kingdom heart failure evaluation and assessment of risk trial (UK-HEART)